Citation Impact
Citing Papers
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
2007 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
1998
Actualización en síndrome hemolítico urémico atípico: diagnóstico y tratamiento. Documento de consenso
2015
Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study
2006
Atypical hemolytic uremic syndrome
2011
Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients
2017
Parenteral Anticoagulants
2012 Standout
Anticoagulant Use in Patients with Chronic Renal Impairment
2005
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Differential Impact of Complement Mutations on Clinical Characteristics in Atypical Hemolytic Uremic Syndrome
2007
Dosage of enoxaparin among obese and renal impairment patients
2004
Acute kidney injury
2012 Standout
Utilisation and Safety of Low Molecular Weight Heparins
2003
Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long‐term followup study
2006
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Polyarteritis Nodosa and Extrahepatic Manifestations of HBV Infection: The Case Against Autoimmune Intervention in Pathogenesis
2001
Small-Vessel Vasculitis
1997 Standout
Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>
2008
Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?
2002
Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database
2018
Growing Significance of Myeloperoxidase in Non-infectious Diseases
2002
Cryoglobulinemia Related to Hepatitis C Virus Infection
2007
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study
2013
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Perioperative Management of Antithrombotic Therapy
2012 Standout
Technical considerations for studying cancer metastasis in vivo
1997
Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b
1997
Health Risks of Herbal Remedies
1995
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Short‐term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus–related polyarteritis nodosa
2004
Hepatitis B Virus-Associated Polyarteritis Nodosa
2005
Comprehensive Genetic Analysis of Complement and Coagulation Genes in Atypical Hemolytic Uremic Syndrome
2013
ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab
2015
Complement: coming full circle
2009
Use of enoxaparin for the chronically anticoagulated patient before and after procedures
1999
Aristolochic Acid and ???Chinese Herbs Nephropathy???
2003
Systemic sclerosis
2017 Standout
Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin
2003
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
2012
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians
2002
Liver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome
2008
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
2013
Microscopic Polyangiitis
2010
Atypical Hemolytic–Uremic Syndrome
2009
Prevention of VTE in Nonsurgical Patients
2012 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Gene conversion causing human inherited disease: Evidence for involvement of non-B-DNA-forming sequences and recombination-promoting motifs in DNA breakage and repair
2009
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Fanconi’s syndrome induced by a monoclonal Vκ3 light chain in Waldenström’s macroglobulinemia
2005
Sarcoidosis
2013 Standout
Hemolytic Uremic Syndrome in Pregnancy and Postpartum
2017
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies
2003
β-Edge Interactions in a Pentadecameric Human Antibody Vκ Domain
2006 StandoutNobel
Treatment of hepatitis C-virus-related glomerulonephritis
2006
Long-term therapy with plasma exchange in systemic sclerosis: effects on laboratory markers reflecting disease activity
2001
Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis
2003
Monitoring of low-molecular-weight heparins in cardiovascular disease
1998
Heparin and Low-Molecular-Weight Heparin
2004
The Pharmacokinetics of Subcutaneous Enoxaparin in End‐Stage Renal Disease
2001
Alveolar Hemorrhage in Anti-Basement Membrane Antibody Disease
2007
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)
2003
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment
2002
Chronic kidney disease: global dimension and perspectives
2013 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Primary systemic vasculitis
1997
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
2007
Acute kidney injury in cirrhosis
2008
Apheresis for MPO-ANCA-associated RPGN—indications and efficacy: Lessons learned from Japan nationwide survey of RPGN
2005
Pulmonary renal syndrome: A 4-year, single-center experience
2002
Prevention of Venous Thromboembolism
2008 Standout
Prognosis of scleroderma renal crisis: a long-term observational study
2012
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes
2002
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis
2003
Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation
2015
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
2016 Standout
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Treatment of HCV in Patients with Renal Failure
2007
Polyarteritis nodosa: A contemporary overview
2016
Trends in Alternative Medicine Use in the United States, 1990-1997
1998 Standout
A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome
2008
A case of Wegener?s granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP)
2004
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Aristolochic acid nephropathy: A worldwide problem
2008 Standout
Crystalline Nephropathies
2012
Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells
2001
Outpatient treatment of deep vein thrombosis: translating clinical trials into practice
1999
Enoxaparin and Bleeding Complications: A Review in Patients with and without Renal Insufficiency
2000
Structure activity relationships of aristolochic acid analogues: Toxicity in cultured renal epithelial cells
2005
Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus
2015
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia
2018
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Low Molecular Weight Heparin Therapy: Is Monitoring Needed?
1994
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Antigen specificity in hydralazine associated ANCA positive systemic vasculitis
1995
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
2006
Reactive oxygen species in cell signaling
2000 Standout
Rituximab for refractory granulomatous eye disease
2012
An Evolutionary View of the Mechanism for Immune and Genome Diversity
2012 StandoutNobel
Economic and Practical Aspects of Thromboprophylaxis With Unfractionated and Low-Molecular-Weight Heparins in Hospitalized Medical Patients
2009
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
A cross‐sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus
2013
Role of neutrophils in the pathogenesis of experimental vasculitis.
1996
Treatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
2015
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
2003 Standout
Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis
1986
How we approach an acquired thrombotic thrombocytopenic purpura patient
2014
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
POLYARTERITIS NODOSA, MICROSCOPIC POLYANGIITIS, AND CHURG-STRAUSS SYNDROME
1995
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Pharmacokinetics and Tolerance of the Natural Pentasaccharide (SR90107/ORG31540) with High Affinity to Antithrombin III in Man
1995
Low-Molecular-Weight Heparins
1997 Standout
Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis
2018
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine
2016 StandoutNobel
Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment.
1995
Correlation of Antifactor Xa Concentrations with Renal Function in Patients on Enoxaparin
2003
TNF inhibitors – Mechanisms of action, approved and off-label indications
2014
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Aristolochic Acid Nephropathy: The Hong Kong Perspective
2007
Myeloperoxidase: friend and foe
2005 Standout
Works of Jacques Pourrat being referenced
Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN
2004
Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome
2006
Treatment of Hepatorenal Syndrome as Defined by the International Ascites Club by Albumin and Furosemide Infusion According to the Central Venous Pressure: A Prospective Pilot Study
2005
Microscopic Polyangiitis with Alveolar Hemorrhage A Study of 29 Cases and Review of the Literature
2000
Blood Concentrations of Hydroxychloroquine and Its Desethyl Derivative Correlate Negatively with the Percentage of CD45RO+ Cells among CD4+ Lymphocytes in Hydroxychloroquine‐Treated Lupus Patients
2007
Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
2012
Adult Faconi Syndrome Secondary to Light Chain Gammopathy: Clinicopathologic Heterogeneity and Unnsual Features in 11 Patients
2000
Delayed elimination of enoxaparine in patients with chronic renal insufficiency
1991
Syndrome pneumo-rénal induit par la d-pénicillamine : Syndrome de Goodpasture ou polyartérite microscopique ?
1990
Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients
2008
Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls
2011
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease
2013
[Nephropathy associated with Chinese herbal drugs. 2 cases].
1994
Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges.
1994
Metastases of human tumor xenografts in nude mice.
1984
Treatment of Progressive Systemic Sclerosis by Plasma Exchange: Long-term Results in 40 Patients
1990
[Anti-polynuclear neutrophil cytoplasmic antibodies of the perinuclear type or p-ANCA].
1992